Circulating p53-responsive microRNAs as predictive biomarkers in heart failure after acute myocardial infarction: The long and arduous road from scientific discovery to clinical utility

Circulation Research

Volumn 113, Issue 3, 2013, Pages 242-244

  Evans, Sarah ^a   Mann, Douglas L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; GALECTIN 3; MICRORNA; MICRORNA 192; MICRORNA 194; MICRORNA 34A; PROTEIN P53; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; CELL SURVIVAL; CELL VIABILITY; DIAGNOSTIC ACCURACY; EDITORIAL; EXOSOME; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EDITORIAL; EXOSOME;

FEMALE; HEART FAILURE; HUMANS; MALE; MICRORNAS; MYOCARDIAL INFARCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880847851     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.301951     Document Type: Editorial

References (11)

1. van Kimmenade RR, Januzzi JL Jr. Emerging biomarkers in heart failure. Clin Chem. 2012;58:127-138.
2. Matsumoto S, Sakata Y, Nakatani D, Suna S, Nakatani D, Usami M, Hara M, Kitamura T, Hamasaki T, Nanto S, Kawahara Y, Komuro I. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113:322-326.
3. Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444-448.
4. Matsumoto S, Sakata Y, Nakatani D, Suma S, Mizuno H, Shimizu M, Usami M, Sasaki T, Sato H, Kawahara Y, Hamasaki T, Nanto S, Hori M, Komuro I. A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun. 2012;427:280-284.
5. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13:486-491.
6. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129:303-317.
7. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res. 2008;103:1072-1083.
8. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011;469:336-342.
9. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298-301.
10. Salic K, De Windt LJ. MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep. 2012;14:193-200.
11. Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34.